The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,939.00
Bid: 1,937.00
Ask: 1,938.00
Change: 7.00 (0.36%)
Spread: 1.00 (0.052%)
Open: 1,926.00
High: 1,948.00
Low: 1,904.00
Prev. Close: 1,932.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE steadies near 3-week low before BoE decision, Hikma sinks

Thu, 04th Aug 2016 09:01

(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

* FTSE 100 steady in morning trade

* Focus on BoE's rate decision

* Hikma slumps after update

By Atul Prakash

LONDON, Aug 4 (Reuters) - Britain's top share index steadiedbefore a likely move by the Bank of England to cut rates onThursday, although drugmaker Hikma and precious metalsminer Randgold Resources slumped after their poorupdates.

The blue-chip FTSE 100 index was flat in percentageterms at 6,635.50 points by 0833 GMT after setting a newthree-week low of 6,615.83 earlier in the day.

Investors keenly awaited the Bank of England's likely movelater in the day to cut interest rates for the first time since2009, as Britain's economy teeters on the brink of recessionafter June's Brexit vote.

"The BoE is expected to cut the bank rate by at least 25basis points and to revise the economic forecasts significantlylower following Britain's decision to leave the European Union,"Ipek Ozkardeskaya, senior analyst at London Capital Group said.

"Of course BoE Governor Mark Carney will remind that amonetary easing will not be enough to solve the problems the UKmay be facing ahead. The Brexit is a major political issue,which will result in a sizeable structural change, hence thefiscal side of the play will be as important, if not more."

Some companies suffered heavily after their updates.

Hikma, down 14.5 percent and heading for its worst one-daypercentage drop in 8 years, led the market lower after sayingthat its full-year core operating profit from its generics unitwould be hurt by delayed approvals of new products andhigher-than-expected costs.

Randgold Resources, down 11.3 percent, also featuredamong the top decliners after it said its second-quarter profitfrom mining was flat as higher gold prices were offset by lowerproduction and increased costs.

"Randgold described Q2 2016 as one of the toughest quartersit has suffered 'in years', with results hit by a 46-day outageat one of Tongon's two milling circuits and throughput, recoveryand dilution challenges at Kibali owing to this mine'scontinuing transition to a mixed-ore feed," Shore Capitalanalyst Yuen Low said in note.

"These disappointments more than offset outperformance atLoulo-Gounkoto. Importantly, however, Randgold expects a betterH2 2016, which it believes should 'boost its 2016 results towithin its market guidance'," Low said.

Some companies gained on the back of strong results.

Aviva was up 4.8 percent after the insurer boostedprofits and cash generation in the first half of the yeardespite a challenging market backdrop, enabling it to raise itsinterim dividend.

Mid-cap company Serco Group surged nearly 12 percentafter the British outsourcing firm raised its 2016 profitforecast for the second time this year and said Britain's voteto leave the European Union could bring opportunities as well ascosts. (Reporting by Atul Prakash; Editing by Raissa Kasolowsky)

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.